2019 PROGRAMME


REGISTER NOW
Last minute registrations: please make sure the payment is received before the event! Many thanks


HOTEL ACCOMMODATION
Hotel reservations are subject to availability so book ASAP!
Sofitel Warsaw Victoria – Reservation Department
P: + 48 22 657 82 85 – E: h3378-re@sofitel.com


ADVERTISING, EXHIBITION & SPONSORSHIP OPPORTUNITIES

Committing to Global Health:

Balancing Access and Sustainability

The Joint 25th Medicines for Europe and 22nd IGBA Annual Conference will bring together over 300 experts including medicine manufacturers, stakeholders and governments to evaluate market trends, innovative commercial strategies, challenges for the pharma sector and new opportunities to improve access to medicines for patients. At this unique event, participants will not only gain new insight but also discuss the commitment of the off-patent industry towards Global Health.

Join us in this unique opportunity to network in the beautiful capital of Poland, Warsaw.

Why should you attend?

  • Get updates on the latest developments and market trends in the off-patent pharmaceutical industry;
  • Meet high-level international speakers to understand the global relevance of Generic, Biosimilar and Value Added Medicines;
  • Network with policy-makers, regulators, payers and peers;
  • Discover business opportunities in pharmaceutical markets around the world.

view the programme

CHAIRPERSONS AND SPEAKERS

Marc-Alexander Mahl
President Medicines for Europe and Executive Vice President, Business Unit Generics and Complex Formulations ELAMA & Asia-Pacific Pharmaceuticals and Devices Division, Fresenius Kabi Deutschland
Marc-Alexander MahlPresident Medicines for Europe and Executive Vice President, Business Unit Generics and Complex Formulations ELAMA & Asia-Pacific Pharmaceuticals and Devices Division, Fresenius Kabi Deutschland
Marcie McClintic Coates
Head of Global Policy, Mylan
Marcie McClintic CoatesHead of Global Policy, Mylan
Randall Stanicky
Managing Director, RBC Capital Markets
Randall StanickyManaging Director, RBC Capital Markets
Per Troein
Vice President Strategic Partners, IQVIA
Per TroeinVice President Strategic Partners, IQVIA
Nick Haggar
Chief Executive Officer, Zentiva
Nick HaggarChief Executive Officer, Zentiva
Karan Ambwani
Head of Commercial Strategy & Alliances, Teva
Karan AmbwaniHead of Commercial Strategy & Alliances, Teva
Mariângela Simão
Assistant Director General for Drug Access, Vaccines and Pharmaceuticals, WHO
Mariângela SimãoAssistant Director General for Drug Access, Vaccines and Pharmaceuticals, WHO
Jim Keon
President - Canadian Generic Pharmaceutical Association (CGPA) and President - Biosimilars Canada
Jim KeonPresident - Canadian Generic Pharmaceutical Association (CGPA) and President - Biosimilars Canada
Tobias Dolle
Associate, FratiniVergano - European Lawyers
Tobias DolleAssociate, FratiniVergano - European Lawyers
Claire Hempshall
Senior Principal, IQVIA
Claire HempshallSenior Principal, IQVIA
David Jauch
Director Government Relations - Fresenius Kabi
David JauchDirector Government Relations - Fresenius Kabi
Warwick Smith
Director General, British Generic Manufacturers Association (BGMA) and British Biosimilars Association (BBA)
Warwick SmithDirector General, British Generic Manufacturers Association (BGMA) and British Biosimilars Association (BBA)
Jonathan Kimball
Vice President of Trade and International Affairs, Association for Accessible Medicines (AAM)
Jonathan KimballVice President of Trade and International Affairs, Association for Accessible Medicines (AAM)
Suzette Kox
Secretary General, International Generic and Biosimilar medicines Association (IGBA)
Suzette KoxSecretary General, International Generic and Biosimilar medicines Association (IGBA)
Dr. Rob Lionberger
Director, Office of Research and Standards, Office of Generic Drugs, FDA
Dr. Rob LionbergerDirector, Office of Research and Standards, Office of Generic Drugs, FDA
Nicholas Cappuccino
Chair of the IGBA Science Committee and IGBA Member of the ICH Management Committee
Nicholas CappuccinoChair of the IGBA Science Committee and IGBA Member of the ICH Management Committee
Deus Mubangizi
Coordinator Prequalification Team (PQT) Regulation of Medicines and other Health Technologies (RHT), World Health Organization (WHO)
Deus MubangiziCoordinator Prequalification Team (PQT) Regulation of Medicines and other Health Technologies (RHT), World Health Organization (WHO)
Frances (Fran) M. Zipp
President & CEO, Lachman Consultant Services Inc.
Frances (Fran) M. ZippPresident & CEO, Lachman Consultant Services Inc.
Matthew Scherer
International Policy Advisor, Europe Office, U.S. Mission to the European Union, U.S. Food and Drug Administration
Matthew SchererInternational Policy Advisor, Europe Office, U.S. Mission to the European Union, U.S. Food and Drug Administration
Aidan Fry
Editor, Generics Bulletin - Informa
Aidan FryEditor, Generics Bulletin - Informa
David R. Gaugh, R.Ph
Senior Vice President for Sciences and Regulatory Affairs, Association for Accessible Medicines (AAM)
David R. Gaugh, R.PhSenior Vice President for Sciences and Regulatory Affairs, Association for Accessible Medicines (AAM)
Sudarshan Jain
Secretary General, Indian Pharmaceutical Alliance
Sudarshan JainSecretary General, Indian Pharmaceutical Alliance
Michele Uda
Director General, Assogenerici and Chair of the Generic Market Access Committee, Medicines for Europe
Michele UdaDirector General, Assogenerici and Chair of the Generic Market Access Committee, Medicines for Europe
Adele Paterson
Chief Executive Officer and Head of Corporate Partnerships, International Health Partners
Adele PatersonChief Executive Officer and Head of Corporate Partnerships, International Health Partners
James Burt
Executive Vice President Europe & MENA, Accord Healthcare Ltd
James BurtExecutive Vice President Europe & MENA, Accord Healthcare Ltd
Deborah M. Autor
Head of Strategic Global Quality & Regulatory Policy, Mylan
Deborah M. AutorHead of Strategic Global Quality & Regulatory Policy, Mylan
Jerzy Starak
President of the Supervisory Board, Polpharma
Jerzy StarakPresident of the Supervisory Board, Polpharma
Markus W. Sieger
CEO and President of the Management Board, Polpharma Group
Markus W. SiegerCEO and President of the Management Board, Polpharma Group
Krzysztof Kopeć
President of the Board, Polish Union of Employers in Pharmaceutical Industry (PZPPF)
Krzysztof KopećPresident of the Board, Polish Union of Employers in Pharmaceutical Industry (PZPPF)
Maciej Miłkowski
Deputy Minister of Health, Poland
Maciej MiłkowskiDeputy Minister of Health, Poland
Stefan Hendriks
Global Head Biopharmaceuticals, Sandoz
Stefan HendriksGlobal Head Biopharmaceuticals, Sandoz
Gustaf Befrits
Coordinator Introduction of Biosimilars, Stockholm County Council, Sweden
Gustaf BefritsCoordinator Introduction of Biosimilars, Stockholm County Council, Sweden
Marnie Peterson
Chief Executive Officer, Generic and Biosimilar Medicines Association, Australia
Marnie PetersonChief Executive Officer, Generic and Biosimilar Medicines Association, Australia
Zorana Maravic
Director of Operations, Digestive Cancers Europe
Zorana MaravicDirector of Operations, Digestive Cancers Europe
Professor Rob Duncombe
Director of Pharmacy, The Christie NHS Foundation Trust and Director, The Christie Pharmacy Company, UK
Professor Rob DuncombeDirector of Pharmacy, The Christie NHS Foundation Trust and Director, The Christie Pharmacy Company, UK
Dr Paul Cornes
Oncologist, Comparative Outcomes Group, UK
Dr Paul CornesOncologist, Comparative Outcomes Group, UK
Francis Arickx
Head Directorate Reimbursement of Medicines and Pharmaceutical Policy, RIZIV-INAMI, Belgium
Francis ArickxHead Directorate Reimbursement of Medicines and Pharmaceutical Policy, RIZIV-INAMI, Belgium
Sofia Romagosa Vilarnau
Junior Projects and Engagement Officer, European Federation of Allergy and Airways Diseases Patients' Associations (EFA)
Sofia Romagosa VilarnauJunior Projects and Engagement Officer, European Federation of Allergy and Airways Diseases Patients' Associations (EFA)
Kenneth V. Phelps
President and Founder, Camargo Pharmaceutical Services
Kenneth V. PhelpsPresident and Founder, Camargo Pharmaceutical Services
Carsten Brockmeyer
Chief Executive Officer, Formycon
Carsten BrockmeyerChief Executive Officer, Formycon
Francesco Balestrieri
Region Head Europe and Incoming ad interim CEO, Sandoz
Francesco BalestrieriRegion Head Europe and Incoming ad interim CEO, Sandoz
TBN
TBN

PLATINUM SPONSOR

GOLD SPONSORS

SILVER SPONSOR

BRONZE SPONSOR

CONFERENCE SPONSORS

Medicines for Europe is honored to be collaborating with the following partners to make this year’s conference

       

          

CONTACT

Lucia Romagnoli
M: +44 (0) 7 562 87 68 73

For more information on advertising, exhibition and sponsorship packages:
Trudy Beks
M: +31 6 4119 0824

Media Requirements and Press Policy
For any other media enquiries:
Kate O’Regan
P: +32 (0)2 239 20 19